Tag: AngioDynamics
Investigator-led initiative supporting PE research launched
AngioDynamics and The PERT Consortium have announced the launch of the ALPHA-PE Research Fund, an investigator-led initiative supporting independent pulmonary embolism (PE) research.
A press...
First patient enrolled in RECOVER-AV trial evaluating AngioDynamics’ AlphaVac F18⁸⁵ system...
AngioDynamics recently announced the first patient enrolment in RECOVER-AV—a prospective, multicentre, multinational, single-arm study evaluating the AlphaVac multipurpose mechanical aspiration (MMA) F1885 system in...
AngioDynamics receives 510(k) clearance for AlphaVac F1885 System in treatment of...
AngioDynamics has announced that the United States Food and Drug Administration (FDA) has cleared their AlphaVac F1885 system for the treatment of pulmonary embolism...
Enrollment complete in APEX-AV study of mechanical aspiration system for acute...
Patient enrollment is now complete in the APEX-AV trial evaluating the safety and efficacy of the AlphaVac F1885 (AngioDynamics) multipurpose mechanical aspiration system for...